Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Taussig Capital launches Multi-Strat Re reinsurance platform

Wednesday, October 03, 2012

amb
Joe Taussig
Bailey McCann, Opalesque New York:

Zurich–based Taussig Capital is launching a new platform that will give hedge fund managers the opportunity to get into reinsurance. Recent entrants into this area include Daniel Einhorn’s Greenlight Re, and Jonathan Bloomer’s Scottish Re. Before them, Warren Buffet, Louis Bacon, and George Soros have each gone into the reinsurance business. According to Joe Taussig, CEO, Taussig Capital, for hedge fund managers who get into reinsurance, they can expect that their reinsurance company will outperform their funds, significantly increase AuM from sources they could not otherwise access, and secure permanent capital.

Reinsurance differs from insurance in that, rather than taking on the processes and costs of individual transactions, the reinsurance company focuses on the balance sheet, handling the transfer of blocks of risk. "You can’t have a small reinsurer," Taussig explains in an interview with Opalesque. However, for hedge fund managers, who are already familiar with how to handle risk, doing that and getting permanent capital as a return can make for a significant opportunity.

The pioneer managers in this area faced significant start-up hurdles in terms of raising the capital, understanding the business, significant compensation commitments and startup costs with no assurance of success, and nurturing the deal from start to finish. According to Taussig, "we have spent many more days on many more projects t......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its